Insider Stock Trading History of Bonderman David


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Bonderman David since year 2005. The trader's CIK number is 860866. At the time of this reporting, Bonderman David is the Director of Kite Pharma, Inc. . (stock ticker symbol KITE). See this page for all insider trading activities at Kite Pharma, Inc. .

Note that in the past BONDERMAN DAVID also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Bonderman David since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-05-09 KITE Kite Pharma, Inc. Buy 50,000 69.50 3,474,750
2014-08-12 CSGP Costar Group Inc Option Ex 5,000 44.86 224,300
2013-09-13 AWI Armstrong World Industries Inc Sale 2,744,425 51.41 141,090,889
2013-08-20 CSGP Costar Group Inc Option Ex 5,000 30.06 150,300
2013-08-19 NTI Northern Tier Energy Lp Sale 11,500,000 22.03 253,345,000
2013-03-27 GPK Graphic Packaging Holding Co Sale 14,152,144 6.72 95,102,407
2013-03-28 GPK Graphic Packaging Holding Co Sale 2,122,821 6.72 14,265,357
2013-02-08 NTI Northern Tier Energy Lp Sale 1,605,000 23.42 37,590,705
2012-11-14 AWI Armstrong World Industries Inc Sale 1,183,591 48.96 57,948,615
2012-05-29 CSGP Costar Group Inc Option Ex 5,000 22.87 114,350
2011-09-13 CSGP Costar Group Inc Option Ex 3,000 17.97 53,910
2010-11-23 NO SYMBOL General Motors Co Buy 800 33.00 26,400
2009-10-02 AWI Armstrong World Industries Inc Buy 1,892 22.31 42,210
2008-05-08 BKC Burger King Holdings Inc Sale 5,850,000 27.41 160,348,500
2008-04-21 WM Washington Mutual Inc Buy 19,900 100,000.00 1,990,000,000
2008-03-18 JCG J Crew Group Inc Sale 3,000,000 42.50 127,500,000
2007-11-19 BKC Burger King Holdings Inc Sale 6,480,000 24.12 156,330,000
2007-11-21 BKC Burger King Holdings Inc Sale 972,000 24.12 23,449,500
2007-10-04 JCG J Crew Group Inc Sale 4,000,000 44.11 176,440,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bonderman David (Director of Kite Pharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.